Targeting Brain-Body Processes in Postural Tachycardia Syndrome: A Pilot Trial of POts Reprocessing Therapy

For decades, medicine has often drawn a sharp line between the body and the mind, treating physical ailments as mechanical failures and emotional struggles as separate, internal events. This division creates a particular problem for people living with Postural Tachycardia Syndrome, or POTS. In this condition, the autonomic nervous system—the body's automatic control center for functions like heart rate and digestion—malfunctions. When a person stands up, their heart rate spikes excessively, leading to dizziness, fainting, nausea, and overwhelming fatigue. While doctors can measure these physical signs, the underlying cause often remains a mystery. Many patients have been told their symptoms are "all in their head," a dismissive phrase that ignores the very real, measurable distress they feel. However, modern neuroscience is beginning to suggest that the brain and body are not separate machines but a single, integrated network. If the brain learns to perceive a harmless situation, like standing up, as a life-threatening danger, it can trigger a cascade of physical symptoms that persist long after the initial trigger has passed. This idea—that the nervous system can get stuck in a loop of false alarms—opens the door to treatments that target the brain's learning processes rather than just the body's symptoms.

Building on this shifting understanding, a team of researchers at Virginia Commonwealth University recently tested a new approach to helping people with POTS. They developed a therapy called POts Reprocessing Therapy, or PORT, which is adapted from a treatment originally designed for chronic pain. The core idea is that the nervous system can be "rewired" through learning. Just as a person can learn to fear a sound after a bad experience, the researchers hypothesized that people with POTS might have learned to react to standing up with a panic response that their body then mimics as a physical crisis. The goal of PORT is to help patients recognize these sensations as false alarms and teach them to calm the nervous system's overreaction. To see if this was possible, the researchers ran a small, early-stage study involving twenty-nine adults with POTS. They divided the group into two: fourteen people received eight weeks of PORT, while fifteen others continued with their usual community care while waiting for a standard medical appointment.

The therapy itself was a structured, weekly process led by health psychologists trained in the method. It began with a medical evaluation to explain to patients that their symptoms were real but likely driven by a misfiring alarm system in the brain rather than a broken heart or blood vessel. Over the next eight sessions, patients engaged in exercises designed to change how they interpreted their bodily feelings. Instead of fearing the dizziness or rapid heartbeat that came with standing, they practiced mindfulness and gradual exposure, learning to view these sensations as safe signals that no longer needed to trigger a panic response. They also worked on managing the anxiety and emotional distress that often accompany chronic illness. The researchers carefully tracked whether patients could stick with the program and whether they felt it helped. The results were encouraging: the therapy was highly feasible, with most participants completing the full eight weeks, and those who finished reported high levels of satisfaction. Many described feeling more in tune with their bodies and less frightened by their symptoms.

When the researchers looked at the health outcomes, the group receiving PORT showed significantly greater improvement than the group receiving standard care. By the end of the eight weeks, the PORT participants reported a substantial drop in the severity of their POTS symptoms, along with notable reductions in anxiety, depression, and the tendency to catastrophize their physical feelings. In contrast, the group waiting for standard care saw little change in their symptoms over the same period. The researchers noted that the improvements were particularly strong for the core POTS symptoms and the psychological distress that often fuels them. However, the study also found that other issues, such as severe fatigue and general pain, did not change much during this short timeframe. This suggests that while the therapy effectively targets the brain-body alarm system driving the orthostatic symptoms, other aspects of the condition may require more time or different approaches to improve.

The study authors are careful to state that this was a pilot trial, meaning it was a small-scale test designed to see if the treatment could work and be delivered safely, not a final proof of its effectiveness. The group was small, and the study was not randomized, which means the results are preliminary and need to be confirmed by larger, more rigorous trials. Despite these limitations, the findings offer a promising new direction for a condition that has long lacked effective treatments. The research suggests that by addressing the brain's role in maintaining these symptoms, it is possible to help patients regain control over their bodies. For the people involved in the study, the experience was not just about reducing symptoms; it was about finding a language that validated their suffering without blaming them. One participant noted that the therapy helped them pinpoint where their symptoms were coming from before they became overwhelming, while another said they finally felt comfortable in their own skin. This small step forward hints at a future where treatments for autonomic disorders focus on the intricate, learnable connection between the mind and the body, offering hope to those who have felt dismissed for too long.